— Know what they know.
Not Investment Advice

VVOS NASDAQ

Vivos Therapeutics, Inc.
1W: +7.9% 1M: -12.1% 3M: -68.5% YTD: -94.0% 1Y: -95.2% 3Y: -96.8% 5Y: -99.9%
$0.15
+0.00 (+1.88%)
 
Weekly Expected Move ±12.2%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Devices · Tech Score Sell · Power 31 · $2.1M mcap · 10M float · 95.21% daily turnover · Short 41% of daily vol

Supply Chain Overview

17 relationships
17
As Filer
counterparties named
0
As Counterparty
mentioned by others
6
Rel. Types
2024-06-14
Earliest Filing
2026-01-16
Latest Filing
supplier: 8 investor: 3 target: 2 acquirer: 2 customer: 1 partner: 1

Counterparties (Filed by VVOS)

17 relationships

Companies named in VVOS's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Vivos Therapeutics, Inc. VVOS customer Company issuing the convertible promissory note 2026-01-16 View
Vivos Therapeutics, Inc. VVOS target Company issuing the Promissory Note 2025-12-05 View
Avondale Capital, LLC — investor Investor purchasing the Promissory Note 2025-12-05 View
Airway Integrated Management Company, LLC YYAI partner Subsidiary providing Guaranty for the Note 2025-12-05 View
Vivos Therapeutics, Inc. VVOS acquirer Grantor entering into Security Agreement 2025-05-23 View
Carefusion 211, Inc. — supplier Supplier of furniture and fixtures 2025-05-23 View
Henry Schein, Inc. HSIC supplier Supplier of lab equipment 2025-05-23 View
Stratasys SSYS supplier Supplier of 3D printing equipment 2025-05-23 View
ASI Medical Inc — supplier Supplier of orthodontic/hygiene delivery system 2025-05-23 View
Edward Don & Company, LLC — supplier Supplier of office furniture and equipment 2025-05-23 View
ASI Dental Specialties — supplier Supplier of dental specialties equipment 2025-05-23 View
Fong Chen Plastic Technology — supplier Supplier of tooling and plastic technology 2025-05-23 View
Prism Plastics Products, Inc. — supplier Supplier of plastic products and tooling 2025-05-23 View
Vivos Therapeutics, Inc. VVOS acquirer Acquired substantially all assets of The Sleep Center of Nevada for $9,000,000. 2025-04-17 View
Vivos Therapeutics, Inc. VVOS target Company announcing strategic alliance and private equity investment 2024-06-14 View
New Seneca Partners, Inc. — investor Private equity sponsor providing $7.5M investment and management advisory services 2024-06-14 View
Seneca Partners — investor Private equity sponsor providing $7.5M investment and management advisory services 2024-06-14 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-10-01 Accountant Change; Exhibits View
2026-09-08 Material Agreement; Unregistered Equity Sales; Exhibits Agreement View
2026-09-08 Material Agreement; Unregistered Equity Sales; Exhibits Agreement View
2026-08-21 Regulation FD; Exhibits View
2026-08-11 Regulation FD; Exhibits View
2026-08-03 Material Agreement; Officer/Director Change; Exhibits Agreement View
2026-07-07 Material Agreement; Unregistered Equity Sales; Bylaws Amendment; Exhibits Agreement View
2026-06-25 Material Agreement; Regulation FD; Exhibits Agreement View
2026-06-16 Material Agreement; Regulation FD; Exhibits Agreement View
2026-06-16 Other Events; Exhibits View
2026-06-08 Material Agreement; Financial Obligation; Delisting Notice; Unregistered Equity Sales; Regulation FD Agreement View
2026-04-22 Delisting Notice View
2026-04-15 Earnings Release; Exhibits View
2026-04-03 Material Agreement; Unregistered Equity Sales; Exhibits Agreement View
2026-02-06 Departure/Election of Directors; Appointment of Officers View
2026-01-20 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme Agreement View
2026-01-16 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2025-12-17 Other Events; Financial Statements and Exhibits View
2025-12-05 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme Agreement View
2025-11-19 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms